InVitria Attends the 9th Annual Biological Production ForumThe 2010 Biological Production Forum discusses cell culture media and productivity gains to optimize biological production. Fort Collins, CO June 15, 2010 - InVitria is attending the 9th Annual Biological Production Forum in Frankfurt, Germany June 21st through the 23rd. This event is centered on both upstream and downstream biological manufacturing. With a blend of networking opportunities and conference sessions, InVitria will be among the top biotechnology companies attending the event. One of the central themes presented at the 2010 forum is ‘Cell Culture Media and Productivity Gains', discussing process improvements to reduce costs and optimize production. InVitria, a leading global supplier of cell culture products that enhance productivity, safety and time to market for companies in the biopharma, regenerative medicine, cell therapy and life science industry, will bring their expertise and knowledge to the forum. "Attending conferences like the Biological Production Forum, allows InVitria to network with existing collaborators and identify new collaborations with customers across Europe," said Brittany Medbery, Marketing Coordinator at InVitria. "With the recent launch of ITSE Animal-Free, InVitria is continually developing products that meet the performance and regulatory needs of cell culture scientists." About InVitria - InVitria.com InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics. For more information about InVitria's products, please e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it . All InVitria products can be purchased online at www.InVitria.com or by calling 1-800-916-8311.
|
-
Blog: The Cell Culture Dish
Strategies for Improving Viral Yield in Vaccine Manufacturing
A recent article in Pharma Times titled "US biopharma: nearly 300 vaccines in R&D," points out that there are currently 300 vaccines either in clinical studies or under review by the Food and Drug Administration (FDA). While not all vaccines are cell culture derived vaccines, it does indicate that a large number of cell culture based viral vaccines are in the pipeline and that perhaps viral vaccine manufacturing should be examined. One area under consideration is how to improve viral yield so that vaccines can be made at lower cost ... Read More
-
Latest News
InVitria Attends the 13th Bi-Annual Cell Culture Engineering Conference
March 29, 2012 - InVitria is attending the 13th Bi-Annual Cell Culture Engineering Conference in Scottsdale, Arizona April 22nd through the 27th. This event is an invitation only conference that includes approximately 350 of the world's top academic and industry cell culture scientists. Topics at the conference range from fundamental science to the engineering challenges of cell culture process development.... read more
